Wendy Perez

Suggest Changes
Learn More
PURPOSE Gefitinib is an oral agent that inhibits the tyrosine kinase of the epidermal growth factor receptor. In phase I trials gefitinib was well tolerated and antitumor activity was seen in(More)
  • 1